Cargando…

Ultra-high-field MR in Prostate cancer: Feasibility and Potential

Multiparametric MRI of the prostate at clinical magnetic field strengths (1.5/3 Tesla) has emerged as a reliable noninvasive imaging modality for identifying clinically significant cancer, enabling selective sampling of high-risk regions with MRI-targeted biopsies, and enabling minimally invasive fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Tenbergen, Carlijn J. A., Metzger, Gregory J., Scheenen, Tom W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113077/
https://www.ncbi.nlm.nih.gov/pubmed/35579785
http://dx.doi.org/10.1007/s10334-022-01013-7
_version_ 1784709521309958144
author Tenbergen, Carlijn J. A.
Metzger, Gregory J.
Scheenen, Tom W. J.
author_facet Tenbergen, Carlijn J. A.
Metzger, Gregory J.
Scheenen, Tom W. J.
author_sort Tenbergen, Carlijn J. A.
collection PubMed
description Multiparametric MRI of the prostate at clinical magnetic field strengths (1.5/3 Tesla) has emerged as a reliable noninvasive imaging modality for identifying clinically significant cancer, enabling selective sampling of high-risk regions with MRI-targeted biopsies, and enabling minimally invasive focal treatment options. With increased sensitivity and spectral resolution, ultra-high-field (UHF) MRI (≥ 7 Tesla) holds the promise of imaging and spectroscopy of the prostate with unprecedented detail. However, exploiting the advantages of ultra-high magnetic field is challenging due to inhomogeneity of the radiofrequency field and high local specific absorption rates, raising local heating in the body as a safety concern. In this work, we review various coil designs and acquisition strategies to overcome these challenges and demonstrate the potential of UHF MRI in anatomical, functional and metabolic imaging of the prostate and pelvic lymph nodes. When difficulties with power deposition of many refocusing pulses are overcome and the full potential of metabolic spectroscopic imaging is used, UHF MR(S)I may aid in a better understanding of the development and progression of local prostate cancer. Together with large field-of-view and low-flip-angle anatomical 3D imaging, 7 T MRI can be used in its full strength to characterize different tumor stages and help explain the onset and spatial distribution of metastatic spread.
format Online
Article
Text
id pubmed-9113077
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-91130772022-05-18 Ultra-high-field MR in Prostate cancer: Feasibility and Potential Tenbergen, Carlijn J. A. Metzger, Gregory J. Scheenen, Tom W. J. MAGMA Review Multiparametric MRI of the prostate at clinical magnetic field strengths (1.5/3 Tesla) has emerged as a reliable noninvasive imaging modality for identifying clinically significant cancer, enabling selective sampling of high-risk regions with MRI-targeted biopsies, and enabling minimally invasive focal treatment options. With increased sensitivity and spectral resolution, ultra-high-field (UHF) MRI (≥ 7 Tesla) holds the promise of imaging and spectroscopy of the prostate with unprecedented detail. However, exploiting the advantages of ultra-high magnetic field is challenging due to inhomogeneity of the radiofrequency field and high local specific absorption rates, raising local heating in the body as a safety concern. In this work, we review various coil designs and acquisition strategies to overcome these challenges and demonstrate the potential of UHF MRI in anatomical, functional and metabolic imaging of the prostate and pelvic lymph nodes. When difficulties with power deposition of many refocusing pulses are overcome and the full potential of metabolic spectroscopic imaging is used, UHF MR(S)I may aid in a better understanding of the development and progression of local prostate cancer. Together with large field-of-view and low-flip-angle anatomical 3D imaging, 7 T MRI can be used in its full strength to characterize different tumor stages and help explain the onset and spatial distribution of metastatic spread. Springer International Publishing 2022-05-17 2022 /pmc/articles/PMC9113077/ /pubmed/35579785 http://dx.doi.org/10.1007/s10334-022-01013-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Review
Tenbergen, Carlijn J. A.
Metzger, Gregory J.
Scheenen, Tom W. J.
Ultra-high-field MR in Prostate cancer: Feasibility and Potential
title Ultra-high-field MR in Prostate cancer: Feasibility and Potential
title_full Ultra-high-field MR in Prostate cancer: Feasibility and Potential
title_fullStr Ultra-high-field MR in Prostate cancer: Feasibility and Potential
title_full_unstemmed Ultra-high-field MR in Prostate cancer: Feasibility and Potential
title_short Ultra-high-field MR in Prostate cancer: Feasibility and Potential
title_sort ultra-high-field mr in prostate cancer: feasibility and potential
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9113077/
https://www.ncbi.nlm.nih.gov/pubmed/35579785
http://dx.doi.org/10.1007/s10334-022-01013-7
work_keys_str_mv AT tenbergencarlijnja ultrahighfieldmrinprostatecancerfeasibilityandpotential
AT metzgergregoryj ultrahighfieldmrinprostatecancerfeasibilityandpotential
AT scheenentomwj ultrahighfieldmrinprostatecancerfeasibilityandpotential